We are live on ! Find out more
PCA

Pallas Capital Advisors Portfolio holdings

AUM $3.25B
1-Year Est. Return 40.07%
This Fund
S&P 500
This Quarter Est. Return
-5.03%
1 Year Est. Return
+40.07%
3 Year Est. Return
+71.82%
5 Year Est. Return
+73.39%
10 Year Est. Return
AUM
$2.41B
AUM Growth
+$71.8M
Cap. Flow
+$273M
Cap. Flow %
11.32%
Top 10 Hldgs %
34.21%
Holding
806
New
226
Increased
355
Reduced
151
Closed
44

Sector Composition

Rank Sector Weight
1 Healthcare 22.96%
2 Technology 13.05%
3 Financials 7.15%
4 Energy 6.12%
5 Consumer Discretionary 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RIG icon
726
Transocean
RIG
$5.82B
$54.3K ﹤0.01%
17,122
+1,790
+12% +$6.28K
HOUS
727
DELISTED
Anywhere Real Estate
HOUS
$51.8K ﹤0.01%
+15,561
New +$55.1K
SERA icon
728
Sera Prognostics
SERA
$81.1M
$51K ﹤0.01%
13,857
+6
+0% +$31
BLND icon
729
Blend Labs
BLND
$386M
$50.7K ﹤0.01%
+15,134
New +$55K
UIS icon
730
Unisys
UIS
$217M
$48.8K ﹤0.01%
+10,621
New +$59.2K
TLRY icon
731
Tilray
TLRY
$622M
$44.5K ﹤0.01%
6,767
+1,723
+34% +$15.9K
OPK icon
732
Opko Health
OPK
$1.02B
$42.9K ﹤0.01%
+25,851
New +$42.6K
CERS icon
733
Cerus
CERS
$474M
$37.4K ﹤0.01%
+26,884
New +$45K
SFIX
734
Stitch Fix
SFIX
$560M
$36K ﹤0.01%
11,091
+318
+3% +$1.45K
EB
735
DELISTED
Eventbrite
EB
$35.7K ﹤0.01%
16,928
+5,803
+52% +$17.4K
NUVB icon
736
Nuvation Bio
NUVB
$2.32B
$35.7K ﹤0.01%
20,279
+3,263
+19% +$7.43K
MRSN
737
DELISTED
Mersana Therapeutics
MRSN
$32.5K ﹤0.01%
+3,781
New +$58.3K
SANA icon
738
Sana Biotechnology
SANA
$980M
$29.5K ﹤0.01%
+17,559
New +$49.1K
NKTX icon
739
Nkarta
NKTX
$172M
$24.2K ﹤0.01%
+13,141
New +$26.9K
NKTR icon
740
Nektar Therapeutics
NKTR
$2.58B
$23.4K ﹤0.01%
+2,298
New +$30K
IRWD icon
741
Ironwood Pharmaceuticals
IRWD
$714M
$21.1K ﹤0.01%
+14,340
New +$34.2K
BLNK icon
742
Blink Charging
BLNK
$87.9M
$20.3K ﹤0.01%
+22,168
New +$25.7K
EDIT icon
743
Editas Medicine
EDIT
$442M
$18.9K ﹤0.01%
+16,275
New +$23.9K
GPRO icon
744
GoPro
GPRO
$126M
$17.9K ﹤0.01%
+26,938
New +$23.8K
IHRT icon
745
iHeartMedia
IHRT
$583M
$17.5K ﹤0.01%
+10,611
New +$21.4K
LESL icon
746
Leslie's
LESL
$11M
$17.5K ﹤0.01%
+1,189
New +$36.5K
LXRX icon
747
Lexicon Pharmaceuticals
LXRX
$1.1B
$16.7K ﹤0.01%
+36,208
New +$22.8K
SMRT icon
748
SmartRent
SMRT
$272M
$16.3K ﹤0.01%
+13,476
New +$18.9K
CLNE icon
749
Clean Energy Fuels
CLNE
$346M
$16.1K ﹤0.01%
+10,361
New +$26.3K
ERAS icon
750
Erasca
ERAS
$6.39B
$15.8K ﹤0.01%
+11,510
New +$19.8K

Similar funds

Pallas Capital Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Pallas Capital Advisors held 806 positions worth $2.41B, up 3.1% from $2.34B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pallas Capital Advisors deployed $273M of net new capital in Q1 2025, opening 226 new positions and adding to 355 existing holdings. Its largest new stake was BlackRock Flexible Income ETF: 369,803 shares worth $19.4M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $30.7M trimmed.

  • Pallas Capital Advisors's largest Q1 2025 buy was BlackRock Flexible Income ETF: 369,803 shares worth $19.4M.
  • Pallas Capital Advisors added most to Janus Henderson Mortgage-Backed Securities ETF in Q1 2025, an estimated $40.2M increase.
  • Pallas Capital Advisors's biggest Q1 2025 reduction was Vanguard Total Bond Market, cutting an estimated $30.7M.
  • Pallas Capital Advisors fully exited iShares US Pharmaceuticals ETF in Q1 2025, selling an estimated $3.83M.
  • Pallas Capital Advisors's ten largest holdings make up 34% of its $2.41B portfolio in Q1 2025.
  • Pallas Capital Advisors opened 226 new positions and closed 44 in Q1 2025.
  • Pallas Capital Advisors's portfolio value rose 3.1% quarter-over-quarter to $2.41B.

Based on Pallas Capital Advisors's 13F filing for Q1 2025, filed 14 Apr 2025.